Clinical trials conducted outside of India – which test drugs for the Indian market – must include Indian subjects, according to a ruling in India last month.
“Bring Your Own Device” (BYOD) in clinical trials will be a “critical component” of future research says Bracket CEO following the company’s acquisition of mProve Health.
Parexel has partnered with Microsoft to advance patient-centric technologies and help deliver on the promise of personalized medicine following a need for efficiency and innovation in drug development.
Evidera has expanded its patient-centered research services, the advancement of which will enable the introduction of better treatments, faster, says team VP.
Niche, small-scale CROs can stand their own – despite a predicted increase in consolidation among small-sized contract services firms – says Clinical Trial Consultants (CTC) and data-focused Quanticate.
Patient iP has been growing its Connected Site Network over the past two years – as it aims to curate one of the largest patient-centric, longitudinal clinical data sets in the world, says CEO.
EQT's acquisition of Certara is a bet on the continued convergence of healthcare and technology as the industry further adopts biosimulation to advance drug development.
Bioclinica has expanded its eHealth App xChange to make a greater range of technologies available to the increasing number of industry stakeholders – many with differing priorities.
Technology is catapulting clinical trials into a 'new era' as scientific breakthroughs bring new opportunities to an industry that has traditionally lacked innovation.
Wearable technology has been making inroads in the clinical trial industry, however several challenges and concerns surrounding lack of experience still stand in the way of increased adoption.
Digital health devices are increasingly being used by the industry to collect patient-generated data in clinical trials and improve medication adherence – and adoption is expected to increase.
Through their strategic commercial partnership, Medidata and SHYFT Analytics are aiming to increase access to healthcare data analytics in clinical trials.
